Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 May 23:13:878776.
doi: 10.3389/fphar.2022.878776. eCollection 2022.

Role of Licochalcone A in Potential Pharmacological Therapy: A Review

Meng-Ting Li  1 , Long Xie  2 , Hai-Mei Jiang  2 , Qun Huang  2 , Rong-Sheng Tong  1 , Xiang Li  2 , Xin Xie  2 , Hong-Mei Liu  1
Affiliations
Review

Role of Licochalcone A in Potential Pharmacological Therapy: A Review

Meng-Ting Li et al. Front Pharmacol. .

Abstract

Licochalcone A (LA), a useful and valuable flavonoid, is isolated from Glycyrrhiza uralensis Fisch. ex DC. and widely used clinically in traditional Chinese medicine. We systematically updated the latest information on the pharmacology of LA over the past decade from several authoritative internet databases, including Web of Science, Elsevier, Europe PMC, Wiley Online Library, and PubMed. A combination of keywords containing "Licochalcone A," "Flavonoid," and "Pharmacological Therapy" was used to help ensure a comprehensive review. Collected information demonstrates a wide range of pharmacological properties for LA, including anticancer, anti-inflammatory, antioxidant, antibacterial, anti-parasitic, bone protection, blood glucose and lipid regulation, neuroprotection, and skin protection. LA activity is mediated through several signaling pathways, such as PI3K/Akt/mTOR, P53, NF-κB, and P38. Caspase-3 apoptosis, MAPK inflammatory, and Nrf2 oxidative stress signaling pathways are also involved with multiple therapeutic targets, such as TNF-α, VEGF, Fas, FasL, PI3K, AKT, and caspases. Recent studies mainly focus on the anticancer properties of LA, which suggests that the pharmacology of other aspects of LA will need additional study. At the end of this review, current challenges and future research directions on LA are discussed. This review is divided into three parts based on the pharmacological effects of LA for the convenience of readers. We anticipate that this review will inspire further research.

Keywords: anticancer; flavonoid; licochalcone A; pharmacological therapy; traditional Chinese medicine.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

FIGURE 1
FIGURE 1
Licochalcone A isolated from Glycyrrhiza uralensis Fisch. ex DC.
FIGURE 2
FIGURE 2
The target organ and cellular mechanisms for anticancer effect of licochalcone A with anticancer activity.
FIGURE 3
FIGURE 3
The signaling pathways of licochalcone A with anticancer activity.
FIGURE 4
FIGURE 4
The mechanisms of licochalcone A with anti-inflammation activity.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Afanasyev O. I., Kuchuk E., Usanov D. L., Chusov D. (2019). Reductive Amination in the Synthesis of Pharmaceuticals. Chem. Rev. 119 (23), 11857–11911. 10.1021/acs.chemrev.9b00383 - DOI - PubMed
    1. Almeida Fontes L. B., Dos Santos Dias D., de Carvalho L. S., Mesquita H. L., da Silva Reis L., Dias A. T., et al. (2014b). Immunomodulatory Effects of Licochalcone A on Experimental Autoimmune Encephalomyelitis. J. Pharm. Pharmacol. 66 (6), 886–894. 10.1111/jphp.12212 - DOI - PubMed
    1. Almeida Fontes L. B., Aarestrup B. J. V., Aarestrup F. M., Da Silva Filho A. A., do Amaral Correa J. O. (2014a). Effects of Licochalcone A on Immunomodulation in a Murine Model of Multiple Sclerosis. Planta Medica 80 (16), 1403. 10.1055/s-0034-1394634 - DOI
    1. Angelova-Fischer I., Neufang G., Jung K., Fischer T. W., Zillikens D. (2014). A Randomized, Investigator-Blinded Efficacy Assessment Study of Stand-Alone Emollient Use in Mild to Moderately Severe Atopic Dermatitis Flares. J. Eur. Acad. Dermatol Venereol. 28 (Suppl. 3), 9–15. 10.1111/jdv.12479 - DOI - PubMed
    1. Angelova-Fischer I., Rippke F., Richter D., Filbry A., Arrowitz C., Weber T., et al. (2018). Stand-alone Emollient Treatment Reduces Flares after Discontinuation of Topical Steroid Treatment in Atopic Dermatitis: A Double-Blind, Randomized, Vehicle-Controlled, Left-Right Comparison Study. Acta Derm. Venereol. 98 (5), 517–523. 10.2340/00015555-2882 - DOI - PubMed